Global vaccine stocks in focus as the U.S. government plans to phase out investment for mRNA vaccine development activities.

Researchers at Fred Hutch Cancer Center invented a new screening method called ReLiC that uses CRISPR-Cas9 to test all the ...

As Moderna has significantly lagged behind the broader market over the past year, Wall Street analysts maintain a cautious ...

Vaccine experts and people steeped in pandemic preparedness expressed horror at the news that RFK Jr. has shut the door in ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

All living organisms' genetic information is stored in DNA, which is transcribed into RNA, which is translated into proteins ...

The US Department of Health and Human Services is ending contracts to develop vaccines using messenger RNA technology, ...

The US Department of Health and Human Services is ending contracts to develop vaccines using messenger RNA technology, another step in the agency's changing practices toward vaccines under Secretary ...

RNA technology is credited with ending the COVID-19 pandemic But Department Secretary Robert F. Kennedy, Jr. says it's ...

I think that's the case with Vertex. Here are seven reasons why Vertex is a no-brainer stock to buy on the dip.

The S&P 500 (^GSPC) is often seen as a benchmark for strong businesses, but that doesn’t mean every stock is worth owning.

— Pilot Adrian Eichhorn, a former US military officer, and pilot Shinji Maeda, a native of Japan, who plan to fly in close ...